# Robert Brenner

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/robert-brenner
Canonical HTML page: https://getbiobrief.com/entity/robert-brenner

## Recent coverage (1 stories)

### Vera’s TRUTAKNA Gets FDA Nod with 42% UPCR Reduction, Awaits Kidney Data
2026-07-12 07:11:54 · Sentiment: Positive · Impact: 8/10 · Sources: 2

Vera Therapeutics scores an accelerated approval for TRUTAKNA in IgA nephropathy, touting a 42% UPCR reduction vs placebo in Phase 3 ORIGIN 3. The dual BAFF/APRIL inhibitor enters a competitive market with a surrogate endpoint—investors await the confirmatory eGFR data.
Full story: https://getbiobrief.com/story/vera-trutakna-fda-accelerated-approval-iga-nephropathy

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.